Hillsdale Investment Management’s Veracyte VCYT Stock Holding History

Hillsdale Investment Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-210	Closed	-$5.68K	–	745
2025 Q2	$5.68K	Hold	210	–	–	﹤0.01%	592
2025 Q1	$6.23K	Hold	210	–	–	﹤0.01%	545
2024 Q4	$8.32K	Hold	210	–	–	﹤0.01%	496
2024 Q3	$7.15K	Buy	+210	New	+$5.91K	﹤0.01%	529
2019 Q4	–	Sell	-34,900	Closed	-$838K	–	666
2019 Q3	$838K	Sell	34,900 -1,000	-3%	-$26.6K	0.07%	237
2019 Q2	$1.02M	Buy	35,900 +6,600	+23%	+$165K	0.1%	167
2019 Q1	$733K	Buy	+29,300	New	+$560K	0.07%	172

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hillsdale Investment Management's VCYT Position: Q3 2025 in Review

Hillsdale Investment Management sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 210 shares — an estimated $5.68K sold.

Hillsdale Investment Management first reported a position in VCYT in Q1 2019 and held it in 7 quarters. The position peaked at $1.02M in Q2 2019. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

Hillsdale Investment Management reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
Hillsdale Investment Management sold 210 Veracyte shares in Q3 2025, an estimated $5.68K.
Hillsdale Investment Management first reported a position in Veracyte in Q1 2019 and held it in 7 quarters.
Hillsdale Investment Management's Veracyte position peaked at $1.02M in Q2 2019.
298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Hillsdale Investment Management's 13F filing for Q3 2025, filed 10 Nov 2025.